Related Experiment Video
Updated: Feb 14, 2026

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion
Daniel Kogan1,2, Alexander Grabner3, Christopher Yanucil4
1Technische Universität München, Munich, Germany.
Abstract:
Immune evasion and the suppression of antitumor responses during cancer progression are considered hallmarks of cancer and are typically attributed to tumor-derived factors. Although the molecular basis for the crosstalk between tumor and immune cells is an area of active investigation, whether host-specific germline variants can dictate immunosuppressive mechanisms has remained a challenge to address. A commonly occurring germline mutation (c.1162G>A/rs351855 G/A) in the FGFR4 (CD334) gene enhances signal transducer and activator of transcription 3 (STAT3) signaling and is associated with poor prognosis and accelerated progression of multiple cancer types. Here, using rs351855 SNP-knockin transgenic mice and Fgfr4-knockout mice, we reveal the genotype-specific gain of immunological function of suppressing the CD8/CD4+FOXP3+CD25+ regulatory T cell ratio in vivo. Furthermore, using knockin transgenic mouse models for lung and breast cancers, we establish the host-specific, tumor-extrinsic functions of STAT3-enhancing germline variants in impeding the tumor infiltration of CD8 T cells. Thus, STAT3-enhancing germline receptor variants contribute to immune evasion through their pleiotropic functions in immune cells.
Insights
Host germline variants, specifically in FGFR4, can enhance STAT3 signaling, promoting cancer immune evasion. This study reveals how these variants suppress antitumor immune responses, impacting cancer progression and patient prognosis.
Area of Science:
- Immunology
- Cancer Biology
- Genetics
Background:
- Cancer progression involves immune evasion and suppressed antitumor responses, often linked to tumor factors.
- The role of host germline variants in dictating cancer immunosuppression remains largely unexplored.
- A common FGFR4 (CD334) germline mutation (rs351855 G/A) enhances STAT3 signaling, correlating with poor cancer prognosis.
Purpose of the Study:
- To investigate the impact of host-specific germline variants on cancer immunosuppression.
- To elucidate the role of FGFR4 variants and STAT3 signaling in immune evasion mechanisms.
- To determine if germline variants can impede anti-tumor immune cell infiltration.
Main Methods:
- Utilized rs351855 SNP-knockin and Fgfr4-knockout transgenic mouse models.
- Assessed genotype-specific immunological functions in vivo.
- Employed knockin mouse models for lung and breast cancers to study tumor-extrinsic effects.
Main Results:
- Demonstrated genotype-specific suppression of the CD8/CD4+FOXP3+CD25+ regulatory T cell ratio.
- Established that STAT3-enhancing germline variants impede CD8 T cell tumor infiltration in lung and breast cancer models.
- Identified tumor-extrinsic functions of germline variants in modulating the immune microenvironment.
Conclusions:
- Host-specific germline variants, particularly in FGFR4, can promote cancer immune evasion.
- STAT3-enhancing germline variants contribute to immunosuppression through pleiotropic effects on immune cells.
- These findings highlight germline genetics as a critical factor in cancer progression and immune response.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
The Extrinsic Apoptotic Pathway
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Mutation, Gene Flow, and Genetic Drift
Viral Mutations

